Envestnet Asset Management Inc. cut its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 7.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 282,285 shares of the industrial products company's stock after selling 24,106 shares during the quarter. Envestnet Asset Management Inc. owned 0.12% of Xylem worth $33,722,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Dempze Nancy E increased its stake in Xylem by 0.3% in the fourth quarter. Dempze Nancy E now owns 25,761 shares of the industrial products company's stock valued at $2,989,000 after purchasing an additional 88 shares during the last quarter. Townsquare Capital LLC increased its holdings in shares of Xylem by 0.8% in the fourth quarter. Townsquare Capital LLC now owns 11,074 shares of the industrial products company's stock valued at $1,285,000 after purchasing an additional 88 shares during the period. Center for Financial Planning Inc. raised its position in Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after buying an additional 91 shares during the last quarter. Keel Point LLC increased its position in Xylem by 4.1% during the 4th quarter. Keel Point LLC now owns 2,371 shares of the industrial products company's stock worth $275,000 after purchasing an additional 93 shares during the period. Finally, SageView Advisory Group LLC lifted its holdings in Xylem by 3.6% in the fourth quarter. SageView Advisory Group LLC now owns 2,790 shares of the industrial products company's stock valued at $324,000 after acquiring an additional 98 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on XYL shares. Stifel Nicolaus boosted their price target on Xylem from $140.00 to $141.00 and gave the stock a "buy" rating in a research note on Wednesday, April 30th. Royal Bank Of Canada raised their target price on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Robert W. Baird lowered their price target on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Raymond James Financial raised Xylem to a "hold" rating in a research report on Thursday, May 15th. Finally, Citigroup reiterated a "buy" rating and set a $152.00 price objective (up from $137.00) on shares of Xylem in a research note on Monday. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $146.29.
Read Our Latest Research Report on XYL
Xylem Stock Up 0.1%
Shares of NYSE XYL traded up $0.12 during midday trading on Tuesday, reaching $131.09. 158,120 shares of the company's stock were exchanged, compared to its average volume of 1,535,499. The business's fifty day moving average price is $127.00 and its two-hundred day moving average price is $122.61. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $143.50. The stock has a market capitalization of $31.90 billion, a PE ratio of 35.24, a price-to-earnings-growth ratio of 2.38 and a beta of 1.12. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.41 and a current ratio of 1.89.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.95 by $0.08. Xylem had a net margin of 10.54% and a return on equity of 10.12%. The business had revenue of $2.07 billion for the quarter, compared to analysts' expectations of $2.04 billion. During the same quarter last year, the company posted $0.90 earnings per share. The company's quarterly revenue was up 1.8% compared to the same quarter last year. Analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 26th. Investors of record on Thursday, May 29th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date was Thursday, May 29th. Xylem's dividend payout ratio is presently 43.01%.
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.